| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702108 | Journal of Thoracic Oncology | 2016 | 10 Pages |
Abstract
We have demonstrated exosome protein profiling to be a promising diagnostic tool in lung cancer independently of stage and histological subtype. Multimarker models could make a fair separation of patients, demonstrating the perspectives of exosome protein profiling as a biomarker.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Birgitte MD, Kristine Raaby MSc, Rikke MSc, Birgitte Holst MD, PhD, Torben Riis MD, PhD, Peter MD, PhD, Kim MD, PhD, Malene Møller MSc, PhD, Boe Sandahl MSc, PhD,